KA-301

N/A

Report date: 2023/08/18 16:39:16

Base Information

Drug NameKA-301
Drug Alias NameKA-301
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsSpinal Cord InjuriesMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesKaneka Corp
China Registration ClassN/A

Develop Information

Active CompaniesKaneka Corp
Inactive CompaniesN/A
Active IndicationsSpinal Cord InjuriesMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A